Rewards
All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
Trending on Bing
'World's rarest album'
‘It's really scary’
Father, teenage son drown
Shark sighting closes beach
Inmates break out of jail
Protesters block LA freeway
Chicago man sues city, police
Slingshot shooter arrested
Son underwent heart surgery
PNG orders evacuations
Closing arguments to begin
Wisc. teens die in crash
Memorial Day travel records
Kilauea eruption study
Retiring after 3 decades
Reaches round 2 in Paris
Honors Bill Walton
$4.4B deal w/ US Cellular
NK spy satellite launch fails
5 people shot in Sacramento
Carbon credit guidelines
Join ‘Knives Out 3′ cast
AI won't 'take your job'
Belgium commits $1B to UKR
Calls to protect civilians
Tanks reach Rafah's center
Fed's Kashkari on rate cuts
Plans to build ad business
Plane catches fire at O'Hare
Tai wins NCAA golf title
Creates oversight board
US grid upgrade plan
CN iPhone shipments up 52%
Storm alert: Fort Worth
'Doing great' after falling ill
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Johnson & Johnson, Kenvue
J&J to exit spinoff Kenvue with latest stake sale
(Reuters) -Tylenol maker Kenvue said on Monday that Johnson & Johnson will sell its remaining 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business.
J&J to Sell Remaining Stake in Kenvue Spinoff
By Dean Seal Johnson & Johnson plans to unload its remaining 9.5% stake in Kenvue in a public offering set about a year after it started splitting
Johnson & Johnson Is Officially Getting Out of Kenvue (KVUE) Stock
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Kenvue (NYSE:KVUE) stock is in the news Monday after the company
J&J to exit Kenvue, a year after spinoff
Tylenol maker Kenvue said on Monday that Johnson & Johnson will offload its entire 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business.
Johnson & Johnson is selling its remaining Kenvue shares
Johnson & Johnson is selling its remaining shares in Kenvue Inc., the consumer-health business that it spun out last year.
Johnson & Johnson Will Sell Remaining Stake in Kenvue (NYSE:KVUE)
Kenvue (NYSE:KVUE) announced on Monday that Johnson & Johnson (NYSE:JNJ) will sell its remaining 9.5% stake in the consumer health company. This
Johnson & Johnson To Sell Entire Stake In Spin-Off Kenvue
Healthcare giant Johnson & Johnson (JNJ) plans to sell its entire stake in spun-off company Kenvue (KVUE). Johnson & Johnson currently holds 182.3 million shares in Kenvue stock. The company plans to sell the shares it owns in a debt-for-equity exchange.
FiercePharma
11d
UPDATED: GSK raises £1.25B through final Haleon share sale
Right on the heels of a similar move by Johnson & Johnson, GSK is offloading the rest of its stake in the consumer healthcare ...
KELO
17d
Sioux Falls drug dealer gets 20 year sentence
SIOUX FALLS, S.D. (KELO.com) — A Sioux Falls drug dealer will be off the streets for a long time. Jason Winckler, 44, was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results